MC
AGN

Miles Capital’s Allergan plc AGN Stock Holding History

Miles Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,609
Closed -$437K – 201
2019
Q2 		$437K Buy
+2,609
New +$361K 0.36% 78
2018
Q4 		– Sell
-1,290
Closed -$246K – 190
2018
Q3 		$246K Buy
+1,290
New +$237K 0.2% 143
2016
Q3 		– Sell
-2,531
Closed -$585K – 223
2016
Q2 		$585K Buy
2,531
+284
+13% +$65.5K 0.4% 57
2016
Q1 		$602K Sell
2,247
-25
-1% -$7.16K 0.4% 63
2015
Q4 		$710K Sell
2,272
-164
-7% -$48.8K 0.48% 52
2015
Q3 		$662K Sell
2,436
-29
-1% -$8.91K 0.48% 48
2015
Q2 		$748K Sell
2,465
-82
-3% -$24.5K 0.49% 50
2015
Q1 		$758K Buy
2,547
+414
+19% +$118K 0.45% 56
2014
Q4 		$549K Buy
+2,133
New +$533K 0.3% 76

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Miles Capital's AGN Position: Q3 2019 in Review

Miles Capital sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 2,609 shares — an estimated $437K sold.

Miles Capital first reported a position in AGN in Q4 2014 and held it in 9 quarters. The position peaked at $758K in Q1 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Miles Capital reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Miles Capital sold 2,609 Allergan plc shares in Q3 2019, an estimated $437K.
  • Miles Capital first reported a position in Allergan plc in Q4 2014 and held it in 9 quarters.
  • Miles Capital's Allergan plc position peaked at $758K in Q1 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Miles Capital's 13F filing for Q3 2019, filed 7 Nov 2019.